Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nadine Muskatel Tung, M.D.

Co-Author

This page shows the publications co-authored by Nadine Tung and Erica Mayer.
Connection Strength

0.759
  1. TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. Ann Oncol. 2020 11; 31(11):1518-1525.
    View in: PubMed
    Score: 0.222
  2. TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline BRCA Carriers With HER2-Negative Breast Cancer (the INFORM trial). J Clin Oncol. 2020 05 10; 38(14):1539-1548.
    View in: PubMed
    Score: 0.215
  3. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014 Aug; 21(8):2506-11.
    View in: PubMed
    Score: 0.144
  4. Contemporary multidisciplinary treatment of pregnancy-associated breast cancer. Springerplus. 2013 Dec; 2(1):297.
    View in: PubMed
    Score: 0.136
  5. Immediate breast reconstruction following mastectomy in pregnant women with breast cancer. J Surg Oncol. 2016 Aug; 114(2):140-3.
    View in: PubMed
    Score: 0.042
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.